Luna Kadouri
Sharett Institute of Oncology
Hebrew University-Hadassah Medical Center
Jerusalem
91120
Israel
Name/email consistency: high
- Absence of founder BRCA1 and BRCA2 mutations in cutaneous malignant melanoma patients of Ashkenazi origin. Kadouri, L., Temper, M., Grenader, T., Abeliovich, D., Hamburger, T., Peretz, T., Lotem, M. Fam. Cancer (2009)
- Glutathione-S-transferase M1, T1 and P1 polymorphisms, and breast cancer risk, in BRCA1/2 mutation carriers. Kadouri, L., Kote-Jarai, Z., Hubert, A., Baras, M., Abeliovich, D., Hamburger, T., Peretz, T., Eeles, R.A. Br. J. Cancer (2008)
- A novel BRCA-1 mutation in Arab kindred from east Jerusalem with breast and ovarian cancer. Kadouri, L., Bercovich, D., Elimelech, A., Lerer, I., Sagi, M., Glusman, G., Shochat, C., Korem, S., Hamburger, T., Nissan, A., Abu-Halaf, N., Badrriyah, M., Abeliovich, D., Peretz, T. BMC. Cancer (2007)
- Polyglutamine repeat length in the AIB1 gene modifies breast cancer susceptibility in BRCA1 carriers. Kadouri, L., Kote-Jarai, Z., Easton, D.F., Hubert, A., Hamoudi, R., Glaser, B., Abeliovich, D., Peretz, T., Eeles, R.A. Int. J. Cancer (2004)
- A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers. Kadouri, L., Kote-Jarai, Z., Hubert, A., Durocher, F., Abeliovich, D., Glaser, B., Hamburger, T., Eeles, R.A., Peretz, T. Br. J. Cancer (2004)
